SCHEMBL8964205

SCHEMBL8964205

COc1cccc(CC(NC(C)=O)(C(=O)O)C(=O)O)c1Oc1ccc([N+](=O)[O-])cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.48
SERPINE1 P05121 4/20 0.42
MEN1 O00255 6/20 0.41
KMT2A Q03164 6/20 0.41
LMNA P02545 5/20 0.41
AGTR2 P50052 1/20 0.41
POLB P06746 1/20 0.41
MAPT P10636 7/20 0.41
PKM P14618 2/20 0.41
GAA P10253 3/20 0.40
KDM4E B2RXH2 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
HTR1A P08908 1/20 0.39
ADRA1D P25100 1/20 0.39
ADRA1A P35348 1/20 0.39
ADRA1B P35368 1/20 0.39
NPC1 O15118 1/20 0.39
HPGD P15428 1/20 0.39
CRHBP P24387 1/20 0.39
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8964199 0.79 ALDH1A1 (0.53) ALDH1A1MEN1KMT2ALMNAMAPT
SCHEMBL8964192 0.77 ALDH1A1 (0.50) ALDH1A1MEN1KMT2ALMNAMAPT
SCHEMBL8875762 0.76 ALDH1A1 (0.48) ALDH1A1SERPINE1MEN1KMT2ALMNA
SCHEMBL8875765 0.76 ALDH1A1 (0.48) ALDH1A1SERPINE1MEN1KMT2ALMNA
SCHEMBL8875770 0.76 ALDH1A1 (0.48) ALDH1A1SERPINE1MEN1KMT2ALMNA
SCHEMBL8964414 0.75 BCHE (0.55) MEN1KMT2ALMNAKDM4EHTT
SCHEMBL8874631 0.73 AGTR2 (0.47) ALDH1A1MEN1KMT2ALMNAAGTR2
SCHEMBL8875431 0.73 AGTR2 (0.47) ALDH1A1MEN1KMT2ALMNAAGTR2
SCHEMBL8874633 0.73 AGTR2 (0.47) ALDH1A1MEN1KMT2ALMNAAGTR2
SCHEMBL7425417 0.72 CYP2C19 (0.47) ALDH1A1MEN1KMT2APOLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5525614-A TREATING VASCULAR RESTENOSIS, CNS DISORDERS WARNER-LAMBERT COMPANY (US) 1996-06-11 US disclosed
US-5489686-A CARDIOVASCULAR DISORDER, NERVOUS SYSTEM DISORDER, ANTIDIURETIC , PSYCHLOGICAL DISORDER, ANTIDEPRESSANTS WARNER-LAMBERT COMPANY (US) 1996-02-06 US disclosed
US-5350757-A Treatment of vascular restenosis, nervous system disorders and cognition enhancement WARNER-LAMBERT COMPANY (US) 1994-09-27 US disclosed
US-5246943-A Substituted 1,2,3,4-tetahydroisoquinolines with angiotensin II receptor antagonist properties WARNER-LAMBERT COMPANY (US) 1993-09-21 US disclosed